NCT03262974View on ClinicalTrials.gov

Effect of Pharmacogenetics on Imatinib Plasma Level and Response

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

October 29, 2017

Primary Completion Date

October 1, 2023

Study Completion Date

October 1, 2023

Conditions
Chronic Myeloid Leukemia
Interventions
DIAGNOSTIC_TEST

PCR

PCR

DIAGNOSTIC_TEST

HPLC-UV

HPLC-UV

Trial Locations (1)

Unknown

South Egypt Cancer Institute, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT03262974 - Effect of Pharmacogenetics on Imatinib Plasma Level and Response | Biotech Hunter | Biotech Hunter